Darolac Aqua Suspension
5ml Suspension in BottleMRP ₹34.13
₹25.60
25% OFF
Made by
ARISTO PHARMACEUTICALS PVT LTD
Dosage
SUSPENSION
Expiry
Product Summary
| Salt Content | Bacillus Subtilis(2.0 Billion Cfu/5ml) |
| Uses | Diarrhoea |
| Therapy | Prebiotic and probiotic |
| Side effects | Skin rash |
Assurance
available
Regulated
Medical Description
Uses
Contraindications
Side effects
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You are hospitalized due to any illness
- You develop any allergic reaction or side effects after taking Darolac Suspension
Directions for Use
- Darolac Suspension should be taken as directed by the doctor
- It is meant for oral use only
- Shake well before use
- Read the instructions on the bottle before usage
Storage and disposal
- Store Darolac Suspension in a clean & dry place away from direct heat, moisture & sunlight
- Keep away from children & pets
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
Frequently Asked Questions (FAQs)
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:DAROLAC
Manufacturer Name:ARISTO PHARMACEUTICALS PVT LTD
Address:Unique Biotech Limited ,Plot No.2 ,Phase- Ii , Alexanda Knowledge Park ,Kolthur Village, Shameetpet Mandal, R.R. Dist, Hydrabad -500078 Telangana, State India
Country of Origin:India
Vendor Details
Fulfillment Information: Darolac 2 BILLION CFU/5ML Suspension (5) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- ENTEROGERMINA® Spores of Poly-antibiotic resistant Bacillus Clausii - 2 billions / 5 mL oral suspension [Internet]. Sanofi.in. 2025 [cited 24 March 2025]
- CDSCO [Internet]. Cdscoonline.gov.in. 2025 [cited 24 March 2025]
- Ghelardi E, Abreu Y Abreu AT, Marzet CB, Álvarez Calatayud G, Perez M 3rd, Moschione Castro AP. Current Progress and Future Perspectives on the Use of Bacillus clausii. Microorganisms. 2022 Jun 17;10(6):1246.[cited 27 Feb 2026]
- Acosta-Rodríguez-Bueno CP, Abreu Y Abreu AT, Guarner F, Guno MJV, Pehlivanoğlu E, Perez M 3rd. Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. Adv Ther. 2022 Nov;39(11):4854-4874.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
